MACQUARIE GROUP LTD - CONMED CORP ownership

CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 279 filers reported holding CONMED CORP in Q1 2022. The put-call ratio across all filers is 3.62 and the average weighting 0.1%.

Quarter-by-quarter ownership
MACQUARIE GROUP LTD ownership history of CONMED CORP
ValueSharesWeighting
Q3 2023$74,993,000
-22.7%
743,613
+4.1%
0.09%
-15.3%
Q2 2023$97,064,000
+22.5%
714,280
-6.4%
0.11%
+18.1%
Q1 2023$79,239,000
+20.0%
762,937
+2.4%
0.09%
+20.5%
Q4 2022$66,034,000
+12.2%
744,969
+1.5%
0.08%
+8.3%
Q3 2022$58,872,000
-14.6%
734,010
+1.9%
0.07%
-6.5%
Q2 2022$68,971,000
-34.2%
720,246
+2.0%
0.08%
-3.8%
Q1 2022$104,854,000
-2.6%
705,854
-7.1%
0.08%
-11.1%
Q4 2021$107,657,000
+5.4%
759,433
-2.7%
0.09%
+3.4%
Q3 2021$102,093,000
-3.6%
780,350
+1.2%
0.09%0.0%
Q2 2021$105,945,000
+10.5%
770,902
+5.0%
0.09%
-36.0%
Q1 2021$95,914,000
+10.4%
734,466
-5.3%
0.14%
+7.1%
Q4 2020$86,880,000
+47.2%
775,717
+3.4%
0.13%
+27.0%
Q3 2020$59,010,000
+10.8%
750,096
+1.3%
0.10%
+8.7%
Q2 2020$53,282,000
+24.9%
740,129
-0.6%
0.09%
+4.5%
Q1 2020$42,663,000
-48.9%
744,944
-0.2%
0.09%
-26.1%
Q4 2019$83,484,000
+20.6%
746,532
+3.7%
0.12%
+2.6%
Q3 2019$69,234,000
-66.0%
720,059
-69.8%
0.12%0.0%
Q2 2019$203,709,000
+205.0%
2,380,593
+196.5%
0.12%
+1.8%
Q1 2019$66,794,000
+28.9%
802,995
-0.5%
0.11%
+14.0%
Q4 2018$51,819,000
-17.3%
807,148
+2.1%
0.10%
-2.0%
Q3 2018$62,643,000
+9.8%
790,740
+1.4%
0.10%
+4.1%
Q2 2018$57,055,000
+13.2%
779,440
-2.1%
0.10%
+6.5%
Q1 2018$50,397,000
+30.8%
795,781
+5.3%
0.09%
+35.3%
Q4 2017$38,519,000
+0.3%
755,724
+3.2%
0.07%
-1.4%
Q3 2017$38,406,000
+17.3%
731,957
+13.9%
0.07%
+15.0%
Q2 2017$32,748,000
+9.3%
642,879
-4.7%
0.06%
+11.1%
Q1 2017$29,961,000
+16.2%
674,656
+15.5%
0.05%
+10.2%
Q4 2016$25,794,000
+14.2%
583,971
+3.6%
0.05%
+14.0%
Q3 2016$22,581,000
-55.9%
563,672
-47.4%
0.04%
-14.0%
Q2 2016$51,156,000
+179.2%
1,071,760
+145.3%
0.05%
+35.1%
Q1 2016$18,321,000
+12.9%
436,840
+18.6%
0.04%
+12.1%
Q4 2015$16,222,000
+0.1%
368,264
+8.4%
0.03%
-5.7%
Q3 2015$16,212,000
-0.2%
339,597
+21.8%
0.04%
+9.4%
Q2 2015$16,250,000
+6.5%
278,882
-7.7%
0.03%
+6.7%
Q1 2015$15,254,000
+62.6%
302,126
+44.8%
0.03%
+57.9%
Q4 2014$9,384,000
+59.2%
208,712
+30.4%
0.02%
+46.2%
Q3 2014$5,896,000
+6.9%
160,056
+28.1%
0.01%
+8.3%
Q2 2014$5,516,000
+15.0%
124,949
+13.2%
0.01%
+50.0%
Q1 2014$4,796,000
+38.6%
110,384
+35.6%
0.01%
+33.3%
Q4 2013$3,461,000
+38.1%
81,425
+10.4%
0.01%
+20.0%
Q3 2013$2,507,000
+4.9%
73,785
-3.5%
0.01%0.0%
Q2 2013$2,390,00076,4900.01%
Other shareholders
CONMED CORP shareholders Q1 2022
NameSharesValueWeighting ↓
Iron Triangle Partners LP 217,204$29,850,0003.08%
Ranger Investment Management 260,524$35,804,0001.87%
EARNEST PARTNERS LLC 1,628,848$223,853,0001.32%
Penn Capital Management Company, LLC 87,232$11,988,0001.16%
DeepCurrents Investment Group LLC 257,334$35,365,0001.06%
Champlain Investment Partners, LLC 1,475,989$202,845,0000.96%
Hood River Capital Management LLC 224,050$30,791,0000.92%
OAK RIDGE INVESTMENTS LLC 74,178$10,194,0000.89%
MOODY ALDRICH PARTNERS LLC 45,667$6,276,0000.88%
WAFRA INC. 138,542$19,040,0000.72%
View complete list of CONMED CORP shareholders